HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter C Doherty Selected Research

Nucleoproteins

1/2013Ecological analysis of antigen-specific CTL repertoires defines the relationship between naive and immune T-cell populations.
5/2011Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals.
2/2007An in vivo cytotoxicity threshold for influenza A virus-specific effector and memory CD8(+) T cells.
11/2006Quantification of repertoire diversity of influenza-specific epitopes with predominant public or private TCR usage.
1/2006A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies.
4/2005Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations.
5/2004Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity.
6/2003Protection and compensation in the influenza virus-specific CD8+ T cell response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter C Doherty Research Topics

Disease

50Infections
01/2020 - 08/2003
44Human Influenza (Influenza)
11/2021 - 06/2003
6Virus Diseases (Viral Diseases)
01/2016 - 06/2005
2Pneumonia (Pneumonitis)
01/2014 - 03/2004
2Neoplasms (Cancer)
05/2011 - 12/2010
2Coinfection
11/2009 - 08/2003
1Reinfection
01/2020
1COVID-19
01/2020
1Inflammation (Inflammations)
01/2016
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2014
1Cytokine Release Syndrome
01/2014
1Bacterial Infections (Bacterial Infection)
05/2013
1Cytomegalovirus Infections (Inclusion Disease)
04/2012
1Necrosis
04/2009
1Influenza in Birds (Avian Flu)
10/2008
1Acquired Immunodeficiency Syndrome (AIDS)
09/2007
1Hypersensitivity (Allergy)
12/2006

Drug/Important Bio-Agent (IBA)

25EpitopesIBA
02/2015 - 08/2003
14Peptides (Polypeptides)IBA
01/2020 - 08/2003
14AntigensIBA
01/2019 - 06/2004
13deoxythymidine 3',5'-bis-(p-nitrophenyl phosphate)IBA
01/2013 - 03/2004
12VaccinesIBA
10/2021 - 04/2005
11CytokinesIBA
11/2021 - 05/2004
9T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2016 - 03/2004
8NucleoproteinsIBA
01/2013 - 06/2003
8AcidsIBA
01/2013 - 06/2003
4Granzymes (Granzyme)IBA
01/2020 - 09/2008
4Antiviral Agents (Antivirals)IBA
01/2016 - 01/2013
4Proteins (Proteins, Gene)FDA Link
01/2013 - 01/2006
3LipopeptidesIBA
10/2015 - 08/2007
3Amino AcidsFDA Link
01/2013 - 04/2005
2Hemagglutinins (Hemagglutinin)IBA
10/2021 - 10/2008
2Influenza Vaccines (Influenza Vaccine)FDA Link
10/2021 - 10/2015
2PerforinIBA
01/2020 - 09/2008
2HLA-A2 Antigen (HLA A2 Antigen)IBA
01/2020 - 05/2011
2ChemokinesIBA
01/2016 - 03/2009
2Phosphotransferases (Kinase)IBA
12/2013 - 05/2013
2T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
05/2011 - 11/2009
2Arginine (L-Arginine)FDA Link
03/2010 - 04/2005
2CollagenIBA
04/2009 - 02/2004
2Indicators and Reagents (Reagents)IBA
07/2008 - 06/2004
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2007 - 03/2004
2Glycoproteins (Glycoprotein)IBA
01/2006 - 03/2004
1HLA-A Antigens (HLA-A)IBA
01/2020
1HLA-DR Antigens (HLA-DR)IBA
01/2020
1Interleukin-18 (Interleukin 18)IBA
01/2016
1Detergents (Detergent)IBA
10/2015
1Peptide Hydrolases (Proteases)FDA Link
02/2014
1InterferonsIBA
01/2014
1MethylprednisoloneFDA LinkGeneric
01/2014
1Sirolimus (Rapamycin)FDA Link
12/2013
1Pharmaceutical PreparationsIBA
12/2013
1Protein Kinases (Protein Kinase)IBA
05/2013
1InflammasomesIBA
05/2013
1Carbon DioxideIBA
04/2013
1Viral RNAIBA
01/2012
1Surface-Active Agents (Surfactants)IBA
01/2011
1Histocompatibility Antigens Class IIBA
12/2010
1SolventsIBA
08/2010
1HLA-B44 AntigenIBA
03/2010
1Fumigant 93 (D-D)IBA
11/2009
1Alanine (L-Alanine)FDA Link
12/2008
1Interleukin-13IBA
11/2008
1Interleukin-10 (Interleukin 10)IBA
11/2008
1phosphomannomutaseIBA
11/2008
1RNA (Ribonucleic Acid)IBA
10/2008
1DNA (Deoxyribonucleic Acid)IBA
10/2008
1Monoclonal AntibodiesIBA
07/2008
1Interleukin-2 (IL2)IBA
08/2007
1Interferon gamma ReceptorIBA
06/2007
1Immunologic Factors (Immunomodulators)IBA
02/2007
1Type II Tumor Necrosis Factor ReceptorsIBA
03/2004
1Integrin alpha1beta1IBA
02/2004
1Immunoglobulin A (IgA)IBA
10/2003
1Immunoglobulin G (IgG)IBA
10/2003

Therapy/Procedure

1Therapeutics
01/2014
1Mechanical Ventilators (Ventilator)
01/2014
1Transplantation
12/2006